Minimal residual disease levels in bone marrow and peripheral blood are comparable in children with T cell acute lymphoblastic leukemia (ALL), but not in precursor-B-ALL
暂无分享,去创建一个
J. V. Dongen | K. Hählen | E. V. Wering | W. Kamps | W. Comans-Bitter | V. V. D. Velden | M. Willemse | A. Wijkhuijs | D. Jacobs
[1] J. V. Dongen,et al. T cell receptor gamma gene rearrangements as targets for detection of minimal residual disease in acute lymphoblastic leukemia by real-time quantitative PCR analysis , 2002, Leukemia.
[2] C. V. D. Schoot,et al. Immunoglobulin kappa deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitative PCR , 2002, Leukemia.
[3] K. Blennow,et al. Transcobalamin polymorphism and homocysteine. , 2001, Blood.
[4] P. Sykes,et al. Molecular relapse can be detected in blood in a sensitive and timely fashion in B-lineage acute lymphoblastic leukemia , 2001, Leukemia.
[5] J. V. Dongen,et al. Real-time quantitative PCR for detection of minimal residual disease before allogeneic stem cell transplantation predicts outcome in children with acute lymphoblastic leukemia , 2001, Leukemia.
[6] A. Órfão,et al. Minimal residual disease in leukaemia patients. , 2001, The Lancet. Oncology.
[7] J. Dongen,et al. Polymerase Chain Reaction, Real-Time Quantitative , 2001 .
[8] A. Berg,et al. Long-term follow-up of Dutch Childhood Leukemia Study Group (DCLSG) protocols for children with acute lymphoblastic leukemia, 1984–1991 , 2000, Leukemia.
[9] F. Behm,et al. Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia. , 2000, Blood.
[10] C. V. D. Schoot,et al. Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia , 2000, Leukemia.
[11] C. Pott,et al. Improved assessment of minimal residual disease in B cell malignancies using fluorogenic consensus probes for real-time quantitative PCR , 2000, Leukemia.
[12] W. Kamps,et al. Regenerating normal B‐cell precursors during and after treatment of acute lymphoblastic leukaemia: implications for monitoring of minimal residual disease , 2000, British journal of haematology.
[13] H. Hooijkaas,et al. Regeneration pattern of precursor-B-cells in bone marrow of acute lymphoblastic leukemia patients depends on the type of preceding chemotherapy , 2000, Leukemia.
[14] H. Gadner,et al. Rapid molecular response during early induction chemotherapy predicts a good outcome in childhood acute lymphoblastic leukemia. , 2000, Blood.
[15] D. Campana,et al. Detection of minimal residual disease in acute leukemia by flow cytometry. , 1999, Cytometry.
[16] C. V. D. Schoot,et al. Suitable DNA isolation method for the detection of minimal residual disease by PCR techniques , 1999, Leukemia.
[17] M. Kami,et al. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood , 1998, The Lancet.
[18] J. Hancock,et al. Minimal Residual Disease Status Before Allogeneic Bone Marrow Transplantation Is an Important Determinant of Successful Outcome for Children and Adolescents With Acute Lymphoblastic Leukemia , 1998 .
[19] C. V. D. Schoot,et al. Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes , 1998, Leukemia.
[20] W. Hop,et al. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood , 1998, The Lancet.
[21] H. Cavé,et al. Clinical Significance of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia , 1998 .
[22] T. Szczepański,et al. Heteroduplex PCR analysis of rearranged T cell receptor genes for clonality assessment in suspect T cell proliferations , 1997, Leukemia.
[23] A. Morley,et al. Monitoring minimal residual disease in peripheral blood in B‐lineage acute lymphoblastic leukaemia , 1997, British journal of haematology.
[24] J. V. Dongen-Melman. Information booklet for parents of children surviving cancer , 1997, Leukemia.
[25] J. V. van Dongen,et al. Detection of minimal residual disease in acute leukemia by immunological marker analysis and polymerase chain reaction. , 1992, Leukemia.
[26] B. Simonsson,et al. Regeneration of CALLA (CD10+), TdT+ and double‐positive cells in the bone marrow and blood after autologous bone marrow transplantation , 1991, European journal of haematology.
[27] D. Campana,et al. Characterization of normal and regenerating bone marrow cells with a panel of monoclonal antibodies. , 2009, Scandinavian journal of haematology.
[28] J. Dongen,et al. Detection of Minimal Residual Acute Lymphoblastic Leukemia by Immunological Marker Analysis: Possibilities and Limitations , 1986 .
[29] J. V. van Dongen,et al. Human bone marrow cells positive for terminal deoxynucleotidyl transferase (TdT), HLA-DR, and a T cell marker may represent prothymocytes. , 1985, Journal of immunology.
[30] A. Hagenbeek,et al. Minimal Residual Disease in Acute Leukemia , 1984, Developments in Oncology.